Literature DB >> 17292973

Normal neutrophil functions in sphingosine kinase type 1 and 2 knockout mice.

Barbara Zemann1, Nicole Urtz, Roland Reuschel, Diana Mechtcheriakova, Frédéric Bornancin, Rudolf Badegruber, Thomas Baumruker, Andreas Billich.   

Abstract

Sphingosine kinase (SPHK) has been implicated as an important element in neutrophil responses to diverse stimulatory agents. To get more insight into the role of the type 1 and 2 isoforms of SPHK in neutrophil functions, we made use of the respective SPHK knockout mice. Neutrophils isolated from the bone marrow of these mice showed normal increase of intracellular Ca(2+) when stimulated in vitro by fMLP, platelet-activating factor, the anaphylatoxin C5a, or ATP, and normal migration towards fMLP and C5a. Also, recruitment of neutrophils into the peritoneum towards the chemokines KC and MIP-2 or to LPS, and into the peripheral blood after fMLP injection was similar in SPHK knockout strains and wild-type animals. An in vivo model of bacterial lung infection revealed an accelerated progression of disease in SPHK2 (but not SPHK1) knockout mice as compared to wild-type controls. However, effector functions of SPHK-deficient neutrophils, such as superoxide production, beta-glucuronidase release and their capacity to kill bacteria were unchanged as compared to wild-type cells. To conclude, the data derived from SPHK knockout mice do not support the hypothesis that any of the two lipid kinases plays a crucial role in signalling downstream of various neutrophil stimuli; SPHKs appear not to be essential for neutrophil recruitment and effector functions.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17292973     DOI: 10.1016/j.imlet.2007.01.001

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  29 in total

1.  Structure-activity relationship studies and in vivo activity of guanidine-based sphingosine kinase inhibitors: discovery of SphK1- and SphK2-selective inhibitors.

Authors:  Neeraj N Patwardhan; Emily A Morris; Yugesh Kharel; Mithun R Raje; Ming Gao; Jose L Tomsig; Kevin R Lynch; Webster L Santos
Journal:  J Med Chem       Date:  2015-02-13       Impact factor: 7.446

Review 2.  Extracellular and intracellular actions of sphingosine-1-phosphate.

Authors:  Graham M Strub; Michael Maceyka; Nitai C Hait; Sheldon Milstien; Sarah Spiegel
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

3.  Sphingosine kinase and sphingosine-1-phosphate: regulators in autoimmune and inflammatory disease.

Authors:  Ashley J Snider
Journal:  Int J Clin Rheumtol       Date:  2013-08-01

Review 4.  Therapeutic potential of targeting sphingosine kinase 1 in prostate cancer.

Authors:  Dmitri Pchejetski; Torsten Böhler; Justin Stebbing; Jonathan Waxman
Journal:  Nat Rev Urol       Date:  2011-09-13       Impact factor: 14.432

5.  Selenoprotein K knockout mice exhibit deficient calcium flux in immune cells and impaired immune responses.

Authors:  Saguna Verma; FuKun W Hoffmann; Mukesh Kumar; Zhi Huang; Kelsey Roe; Elizabeth Nguyen-Wu; Ann S Hashimoto; Peter R Hoffmann
Journal:  J Immunol       Date:  2011-01-10       Impact factor: 5.422

6.  A role for sphingosine kinase 1 in dextran sulfate sodium-induced colitis.

Authors:  Ashley J Snider; Toshihiko Kawamori; Sarah G Bradshaw; K Alexa Orr; Gary S Gilkeson; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2008-09-24       Impact factor: 5.191

7.  Sphingosine kinase 2 promotes lipotoxicity in pancreatic β-cells and the progression of diabetes.

Authors:  Ziyu Song; Wei Wang; Ning Li; Sishan Yan; Kuan Rong; Tian Lan; Pu Xia
Journal:  FASEB J       Date:  2018-11-19       Impact factor: 5.191

Review 8.  Sphingosine-1-phosphate, FTY720, and sphingosine-1-phosphate receptors in the pathobiology of acute lung injury.

Authors:  Viswanathan Natarajan; Steven M Dudek; Jeffrey R Jacobson; Liliana Moreno-Vinasco; Long Shuang Huang; Taimur Abassi; Biji Mathew; Yutong Zhao; Lichun Wang; Robert Bittman; Ralph Weichselbaum; Evgeny Berdyshev; Joe G N Garcia
Journal:  Am J Respir Cell Mol Biol       Date:  2013-07       Impact factor: 6.914

9.  Targeting sphingosine kinase 1 attenuates bleomycin-induced pulmonary fibrosis.

Authors:  Long Shuang Huang; Evgeny Berdyshev; Biji Mathew; Panfeng Fu; Irina A Gorshkova; Donghong He; Wenli Ma; Imre Noth; Shwu-Fan Ma; Srikanth Pendyala; Sekhar P Reddy; Tong Zhou; Wei Zhang; Steven A Garzon; Joe G N Garcia; Viswanathan Natarajan
Journal:  FASEB J       Date:  2013-01-11       Impact factor: 5.191

Review 10.  Sphingolipid signaling in metabolic disorders.

Authors:  Timothy Hla; Andrew J Dannenberg
Journal:  Cell Metab       Date:  2012-09-13       Impact factor: 27.287

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.